Stryker, a provider of medical technologies, has expanded its peripheral vascular portfolio with the introduction of the Artix Thrombectomy System following its acquisition of Inari Medical.
The system aims to cater to the specific needs of peripheral arterial cases, combining aspiration and mechanical thrombectomy to offer enhanced procedural control and adaptability. This launch is anticipated to elevate standards in arterial thrombectomy practices.
According to Stryker, arterial blood clots in the leg represent a critical emergency requiring swift intervention.
Current treatments for arterial thromboembolism present several challenges. These include incomplete clot retrieval, which may necessitate further procedures such as open surgery or amputation, and considerable blood loss.
There are also adverse events like arterial embolisation and vessel trauma, along with high lytic usage rates that can result in complications.
Inari Medical chief medical officer Tom Tu said: “There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy.
“We are excited to bring Inari’s core competency in thrombectomy to the arterial space with the goal of improving outcomes.”
The Artix system, which builds on the success of Inari Medical’s venous thrombectomy devices, represents the company’s initial foray into the arterial arena.
It is said to provide a comprehensive toolkit for arterial thrombectomy, featuring an over-the-wire system that enables physicians to aspirate or mechanically extract clots with increased flexibility.
Key components of the Artix system include a dual mechanical thrombectomy and aspiration toolkit. This is designed to efficiently remove both acute and chronic clots within a single session.
The system also features an 8 Fr. low-profile, trackable, kink-resistant sheath available in 65cm and 90cm lengths. This broadens treatment options by allowing for more complex and distal interventions.
Additionally, there is an over-the-wire mechanical element specifically designed to capture and retrieve clots effectively. A covered nitinol mesh funnel provides temporary flow restriction during procedures to minimize the risk of arterial clot migration.
Last month, Stryker concluded its acquisition of Inari Medical, marking its entry into the rapidly expanding peripheral vascular segment.
Inari Medical’s product offerings complement Stryker’s Neurovascular business and include two novel mechanical thrombectomy solutions, which are the FlowTriever System for pulmonary embolism treatment and the ClotTriever System for peripheral vessel thrombectomy.
The acquisition, announced in January 2025, was valued at $80 per share in cash, culminating in a total fully diluted equity value of about $4.9bn.
